Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.

被引：0
|
作者：
Mannucci, PM
Kyrle, PA
Schulman, S
Haertel, S
Lethagen, S
机构：
[1] Univ Milan, Ctr Hemophilia & Thrombosis Angelo Bianchi Bonomi, Milan, Italy
[2] Univ Clin Vienna, Dept Hematol Hemostaseol, Vienna, Austria
[3] Karolinska Hosp, Dept Coagulat, S-10401 Stockholm, Sweden
[4] Aventis Behring GmbH, Dept Clin Res & Dev Europe, Marburg, Germany
[5] Univ Clin Malmo, Dept Coagulat, Malmo, Sweden
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1121
引用
收藏
页码：312A / 312A
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and dose linearity of von Willebrand factor factor VIII concentrate (Humate-P®) in elective surgery in von Willebrand disease patients.
    DiPaola, J
    Gill, J
    Bernstein, J
    Leissinger, C
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 510A
  • [2] von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    Gill, J. C.
    Shapiro, A.
    Valentino, L. A.
    Bernstein, J.
    Friedman, C.
    Nichols, W. L.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2011, 17 (06) : 895 - 905
  • [3] Pharmacokinetic evaluation of Von Willebrand factor/factor VIII concentrate (Humate-P@) prior to elective surgery in patients with Von Willebrand disease.
    Di Paola, Jorge
    Gill, Joan
    Bemstein, Jonathan
    Leissinger, Cindy
    Ragni, Margaret
    Shopnik, Rinah
    Valentino, Leonard
    Friedman, Carl
    Knaub, Sigurd
    [J]. BLOOD, 2006, 108 (11) : 98B - 99B
  • [4] Efficacy and safety of factor VIII/von Willebrand factor concentrate Haemate P in von Willebrand patients undergoing surgery
    Zotz, R.
    Mandaliev, A.
    Moeller, N.
    Scharf, R.
    [J]. HAEMOPHILIA, 2008, 14 : 118 - 118
  • [5] Treatment with continuous infusion of a factor VIII von Willebrand factor concentrate (Haemate P(R)) for surgery in patients with von Willebrand disease
    Schulman, S
    Varon, D
    Martinowitz, U
    Gitel, S
    Inbal, A
    [J]. BLOOD, 1995, 86 (10) : 754 - 754
  • [6] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    [J]. BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
  • [7] Pharmacokinetic evaluation before surgery of two patients affected by von Willebrand disease and treated with von Willebrand factor/factor VIII concentrate Wilate®
    Preti, P. S.
    Bertolino, G.
    Spataro, C.
    Ciola, M.
    Ambaglio, C.
    [J]. HAEMOPHILIA, 2019, 25 : 153 - 153
  • [8] Safety and efficacy of von Willebrand factor/factor VIII concentrate (Humate-P®) for prophylaxis of excessive bleeding during elective surgery in patients with von Willebrand disease.
    Bernstein, Jonathan
    Gill, Joan Cox
    Leissinger, Cindy A.
    Di Paola, Jorge
    Ragni, Margaret V.
    Shopnick, Rinah
    Valentino, Leonard A.
    Friedman, Carl
    Knaub, Sigurd
    [J]. BLOOD, 2006, 108 (11) : 98B - 98B
  • [9] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [10] Efficacy of factor VIII/von Willebrand factor concentrate Alphanate® in preventing excessive bleeding during surgery in subjects with von Willebrand disease
    Rivard, G. E.
    Aledort, L.
    [J]. HAEMOPHILIA, 2008, 14 (02) : 271 - 275
12345